These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29424785)

  • 21. The Differential Effects of Human Immunodeficiency Virus and Hepatitis C Virus on Bone Microarchitecture and Fracture Risk.
    Bedimo RJ; Adams-Huet B; Poindexter J; Brown G; Farukhi I; Castanon R; Turner D; Moore T; Tebas P; Maalouf NM
    Clin Infect Dis; 2018 Apr; 66(9):1442-1447. PubMed ID: 29145609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone Density, Microarchitecture, and Tissue Quality Long-term After Kidney Transplant.
    Pérez-Sáez MJ; Herrera S; Prieto-Alhambra D; Nogués X; Vera M; Redondo-Pachón D; Mir M; Güerri R; Crespo M; Díez-Pérez A; Pascual J
    Transplantation; 2017 Jun; 101(6):1290-1294. PubMed ID: 27467533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients.
    Casado JL; Santiuste C; Vazquez M; Bañón S; Rosillo M; Gomez A; Perez-Elías MJ; Caballero C; Rey JM; Moreno S
    AIDS; 2016 Jun; 30(9):1423-31. PubMed ID: 26919733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Human Immunodeficiency Virus Infection With Tenofovir Disoproxil Fumarate-Containing Antiretrovirals Maintains Low Bone Formation Rate, But Increases Osteoid Volume on Bone Histomorphometry.
    Ramalho J; Martins CSW; Galvão J; Furukawa LN; Domingues WV; Oliveira IB; Dos Reis LM; Pereira RM; Nickolas TL; Yin MT; Eira M; Jorgetti V; Moyses RM
    J Bone Miner Res; 2019 Sep; 34(9):1574-1584. PubMed ID: 31269294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of trabecular bone score, an index of bone microarchitecture, in HIV positive and HIV negative persons within the HIV UPBEAT cohort.
    McGinty T; Cotter AG; Sabin CA; Macken A; Kavanagh E; Compston J; Sheehan G; Lambert J; Mallon PWG;
    PLoS One; 2019; 14(3):e0213440. PubMed ID: 30897099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of renal tubular dysfunction on bone in tenofovir-exposed HIV-positive patients.
    Hamzah L; Samarawickrama A; Campbell L; Pope M; Burling K; Fisher M; Gilleece Y; Walker-Bone K; Post FA
    AIDS; 2015 Sep; 29(14):1785-1792. PubMed ID: 26372384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco.
    Liu AY; Vittinghoff E; Sellmeyer DE; Irvin R; Mulligan K; Mayer K; Thompson M; Grant R; Pathak S; O'Hara B; Gvetadze R; Chillag K; Grohskopf L; Buchbinder SP
    PLoS One; 2011; 6(8):e23688. PubMed ID: 21897852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection.
    Bedimo R; Rosenblatt L; Myers J
    HIV Clin Trials; 2016 Nov; 17(6):246-266. PubMed ID: 27809711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
    Assoumou L; Katlama C; Viard JP; Bentata M; Simon A; Roux C; Kolta S; Costagliola D; Rozenberg S;
    AIDS; 2013 Sep; 27(15):2425-30. PubMed ID: 24029735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents.
    Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Sophonphan J; Ananworanich J; Puthanakit T;
    Antivir Ther; 2017; 22(6):471-479. PubMed ID: 27786155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment.
    Wilkins EL; Cohen CJ; Trottier B; Esser S; Smith DE; Haas B; Brinson C; Garner W; Chuck S; Thorpe D; De-Oertel S
    AIDS Care; 2016; 28(3):401-8. PubMed ID: 26489045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrepancy between bone density and bone material strength index in three siblings with Camurati-Engelmann disease.
    Herrera S; Soriano R; Nogués X; Güerri-Fernandez R; Grinberg D; García-Giralt N; Martínez-Gil N; Castejón S; González-Lizarán A; Balcells S; Diez-Perez A
    Osteoporos Int; 2017 Dec; 28(12):3489-3493. PubMed ID: 28842728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal change in bone mineral density among Chinese individuals with HIV after initiation of antiretroviral therapy.
    Guo F; Song X; Li Y; Guan W; Pan W; Yu W; Li T; Hsieh E
    Osteoporos Int; 2021 Feb; 32(2):321-332. PubMed ID: 32803316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.
    Shevroja E; Lamy O; Kohlmeier L; Koromani F; Rivadeneira F; Hans D
    J Clin Densitom; 2017; 20(3):334-345. PubMed ID: 28734710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-administration of elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine and atazanavir in treatment-experienced HIV patients.
    Biagi M; Badowski ME; Chiampas T; Young J; Patel M; Vaughn P
    Int J STD AIDS; 2017 Jul; 28(8):766-772. PubMed ID: 27587601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact microindentation in men with impaired fasting glucose and type 2 diabetes.
    Holloway-Kew KL; Betson A; Rufus-Membere PG; Gaston J; Diez-Perez A; Kotowicz MA; Pasco JA
    Bone; 2021 Jan; 142():115685. PubMed ID: 33049369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Teriparatide and Sequential Minodronate on Lumbar Spine Bone Mineral Density and Microarchitecture in Osteoporosis.
    Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M
    Calcif Tissue Int; 2017 Oct; 101(4):396-403. PubMed ID: 28589205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The trabecular bone score: Relationships with trabecular and cortical microarchitecture measured by HR-pQCT and histomorphometry in patients with chronic kidney disease.
    Ramalho J; Marques IDB; Hans D; Dempster D; Zhou H; Patel P; Pereira RMR; Jorgetti V; Moyses RMA; Nickolas TL
    Bone; 2018 Nov; 116():215-220. PubMed ID: 30098418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trabecular bone score (TBS) is associated with sub-clinical vertebral fractures in HIV-infected patients.
    Ciullini L; Pennica A; Argento G; Novarini D; Teti E; Pugliese G; Aceti A; Conti FG
    J Bone Miner Metab; 2018 Jan; 36(1):111-118. PubMed ID: 28233186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.
    Havens PL; Stephensen CB; Van Loan MD; Schuster GU; Woodhouse LR; Flynn PM; Gordon CM; Pan CG; Rutledge B; Liu N; Wilson CM; Hazra R; Hosek SG; Anderson PL; Seifert SM; Kapogiannis BG; Mulligan K;
    Clin Infect Dis; 2017 Feb; 64(3):317-325. PubMed ID: 28013265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.